EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

A Case of ROS1-Fusion Non-Small Cell Lung Cancer with Acquired BRAF Mutation Developing Unusual Skin Metastasis

Wahed A Firoz, Fatma Sen, Maija Kiuru, Victor Huang, Jonathan W Riess

Clinical Lung Cancer · 2024

DOI: 10.1016/j.cllc.2024.01.008 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical Lung Cancer, 2024. Verfasst von Wahed A Firoz und 4 weiteren Autor:innen. Beteiligte Einrichtung: UC Davis Comprehensive Cancer Center, Sacramento, CA. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins B-raf, Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Skin Neoplasms. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The ROS Proto-oncogene 1 (ROS1) fusion mutation occurs in approximately 2% of patients with non-small cell lung cancer (NSCLC) and is readily targetable with receptor-tyrosine kinase inhibitors (RTKIs) such as crizotinib.1,2 However, ROS1-fusion NSCLC has been associated with acquired molecular alterations, either on target ROS1 mutations such as G2032R or bypass tracts such as EGFR, KRAS, and BRAF V600E mutations, which can introduce mechanisms of disease resistance towards targeted therapies.2 Here, we present a case of a patient with an ROS1-fusion NSCLC who developed a BRAF V600E mutation, which subsequently manifested with an unusual cutaneous manifestation of metastatic NSCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins B-rafLung NeoplasmsCarcinoma, Non-Small-Cell LungSkin NeoplasmsMutationProto-Oncogene ProteinsProtein-Tyrosine KinasesHumansMaleMiddle AgedFemale

Stichwörter der Autor:innen

Bypass track resistanceCutaneous eruptionLung adenocarcinomaOncogenic driver mutationsROS1 tyrosine kinase inhibitor

Substanzen

Proto-Oncogene Proteins B-rafROS1 protein, humanBRAF protein, humanProto-Oncogene ProteinsProtein-Tyrosine Kinases

Autor:innen und Institutionen

  • UC Davis Comprehensive Cancer Center, Sacramento, CA.
  • Department of Radiology, University of California, Davis, Sacramento, CA.
  • Department of Dermatology, University of California, Davis, Sacramento, CA; Department of Pathology and Laboratory Medicine, University of California, Davis, Sacramento, CA.
  • Department of Dermatology, University of California, Davis, Sacramento, CA.
  • UC Davis Comprehensive Cancer Center, Sacramento, CA; Division of Hematology/Oncology, Department of Internal Medicine, University of California, Davis, Sacramento, CA. Electronic address: jwriess@ucdavis.edu.

Zitieren

APA

Firoz, W. A., Sen, F., Kiuru, M., Huang, V., & Riess, J. W. (2024). A Case of ROS1-Fusion Non-Small Cell Lung Cancer with Acquired BRAF Mutation Developing Unusual Skin Metastasis. Clinical Lung Cancer. https://doi.org/10.1016/j.cllc.2024.01.008

Vancouver

Firoz WA, Sen F, Kiuru M, Huang V, Riess JW. A Case of ROS1-Fusion Non-Small Cell Lung Cancer with Acquired BRAF Mutation Developing Unusual Skin Metastasis. Clinical Lung Cancer. 2024. doi:10.1016/j.cllc.2024.01.008

BibTeX
@article{Firoz2024,
  author = {Firoz, Wahed A and Sen, Fatma and Kiuru, Maija and Huang, Victor and Riess, Jonathan W},
  title = {A Case of ROS1-Fusion Non-Small Cell Lung Cancer with Acquired BRAF Mutation Developing Unusual Skin Metastasis},
  journal = {Clinical Lung Cancer},
  year = {2024},
  doi = {10.1016/j.cllc.2024.01.008}
}
Kostenlos starten →